Shares of Humana Inc. rose 3.83% to $237.98 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.40% to 6,388.64 and the Dow Jones ...

A majority of Americans have experienced the frustration of getting a healthcare insurance denial, often times finding no ...

Dodge & Cox Stock Fund stays focused amid market swings, boosting value with Health Care picks. Discover how disciplined ...

Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 5.7% in the afternoon session after the investment firm Stephens ...

A recent legal setback has put Humana Inc. (NYSE:HUM), a major player in the U.S. health insurance sector, in the spotlight.

Humana losing star ratings is a big set-back that lead to its share price falling by 7.5% before paring losses.

Humana (HUM) stock falls as the company loses a lawsuit over its 2025 Medicare Star Ratings cut. Read more here.

Humana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past ...

The roller-coaster ride for Regencell Bioscience Holdings shares continued Monday.

Investors were feeling a little more edge on Monday, although the mood on Wall Street remained calm as one of the most unpredictable quarters in recent memory draws to a close. The Cboe Volatility ...

Humana Inc. (NYSE:HUM – Get Free Report) has earned a consensus rating of “Hold” from the twenty-three research firms that are covering the stock, Marketbeat Ratings reports. Sixteen ...

Extreme Stock Volatility: The stock exhibits a heightened sensitivity to overall market conditions. For instance, during the inflation shock of 2022, BBAI’s shares dropped 95% while the S&P 500 ...